The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study

Piet Geusens*, Mary Oates, Akimitsu Miyauchi, Jonathan D Adachi, Marise Lazaretti-Castro, Peter R Ebeling, Carlos Augusto Perez Niño, Cassandra E Milmont, Andreas Grauer, Cesar Libanati

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)
Original languageEnglish
Article numbere10211
Number of pages5
JournalJBMR plus
Volume3
Issue number10
DOIs
Publication statusPublished - Oct 2019

Keywords

  • ANABOLICS
  • CLINICAL TRIALS
  • FRACTURE RISK ASSESSMENT
  • FRACTURE PREVENTION
  • OSTEOPOROSIS

Cite this